Palavra-chave: IMATINIB

LEUCEMIA MIELOIDE CRÔNICA BCR/ABL STEM CELL TRANSPLANTATION CYTARABINE MESILATO NILOTINIB CHRONIC MEYLOID LEUKEMIA FIRST-LINE EUTOS SCORE OCULAR K562 CELLS FRONTLINE MITOXANTRONE KIT K5091 CML-CP MOLECULAR RESPONSE DASATINIB-TREATED LASOR F359V CITARABINA CYTOGENETIC CHRONIC MYELOGENOUS LEUKEMIA PHASE 2 MOLECULAR RNAS TRANSPORTER GENES NON-MYELOABLATIVE CML START BCR/ABL GENE BCR-ABL LALNET PHARMAECONOMIC STUDY CYTOGENETIC REMISSION CHRONIC MYELOID LEUKEMIA BCR-ABL MUTATIONS OBSERVATIONAL CHRONIC MYELOID LEUKAEMIA MYELOGENOUS LEUKEMIA CHRONIC MYELOID LEUCEMIA DISCONTINUATION CHRONIC PHASE MR4.5 BCL/ABL LEUCEMIA MIELÓIDE CRÔNICA CHRONIC MYELOID LEUCEMIA (CML) IRS-1 GENERIC LEUCEMIA MIELÓIDE CRÔNICA (LMC-PB) TREATMENT-FREE REMISSION CRONIC LYMPHOCYTIC LEUKEMIA LOW EDUCATION LEVEL CHILDREN AND ADOLESCENTS DASATINIB LEUCEMIA MIELÓDE CRÔNICA TYROSINE KINASE INHIBITORS BRAZIL ANEMIA FALCIFORME LEUCEMIA MIELÓIDE CRÔNICA (LMC) POLYMORPHISMS PROTEIN-CODING